Cargando…

Maternal allergen immunisation to prevent sensitisation in offspring: Th2-polarising adjuvants are more efficient than a Th1-polarising adjuvant in mice

BACKGROUND: Allergy has been an increasing problem in several parts of the world. Prenatal exposure to allergen and microbial components may affect the development of allergies in childhood, as indicated by epidemiological and experimental studies. We investigated the capacity for allergic sensitisa...

Descripción completa

Detalles Bibliográficos
Autores principales: Ellertsen, Linda K, Nygaard, Unni C, Melkild, Ingrid, Løvik, Martinus
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2846879/
https://www.ncbi.nlm.nih.gov/pubmed/20193059
http://dx.doi.org/10.1186/1471-2172-11-8
_version_ 1782179509845360640
author Ellertsen, Linda K
Nygaard, Unni C
Melkild, Ingrid
Løvik, Martinus
author_facet Ellertsen, Linda K
Nygaard, Unni C
Melkild, Ingrid
Løvik, Martinus
author_sort Ellertsen, Linda K
collection PubMed
description BACKGROUND: Allergy has been an increasing problem in several parts of the world. Prenatal exposure to allergen and microbial components may affect the development of allergies in childhood, as indicated by epidemiological and experimental studies. We investigated the capacity for allergic sensitisation in offspring after induction of a Th1- or a Th2-polarised immune response to the same allergen in mothers during pregnancy. RESULTS: During pregnancy, mice were immunised with ovalbumin (OVA) given with either one of the Th2-adjuvants pertussis toxin (PT) or Al(OH)(3 )(aluminium hydroxide), or with the Th1 adjuvant CpG. Offspring were immunised with OVA in Al(OH)(3 )as young adults. Serum and supernatants from ex vivo stimulated or non-stimulated spleen cells from mothers and offspring were analysed for OVA-specific antibodies and cytokines, respectively. Mothers immunised with OVA together with either Al(OH)(3 )or PT had increased levels of OVA-specific IgE and IgG1 compared to naive mothers, whereas mothers immunised with OVA together with CpG had increased levels of OVA-specific IgG2a compared to naive mothers. In general the highest levels of IL-5, IL-10, and IFNγ were observed in spleen cells from mothers immunised with PT and OVA. Upon immunisation, offspring from mothers immunised with OVA and either PT or Al(OH)(3 )showed reduced levels of OVA-specific IgE and IgG1 and increased levels of OVA-specific IgG2a antibodies compared to offspring from naive mothers. Maternal immunisation with CpG and OVA did not affect antibody responses in offspring. CONCLUSION: Allergic sensitisation in the offspring was affected by the type of adjuvant used for immunisation of the mothers with the same allergen. Th2 polarisation of the immune response in the mothers was found to give reduced IgE levels upon sensitisation of the offspring, whereas no reduction was achieved with Th1 polarisation in the mothers.
format Text
id pubmed-2846879
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-28468792010-03-30 Maternal allergen immunisation to prevent sensitisation in offspring: Th2-polarising adjuvants are more efficient than a Th1-polarising adjuvant in mice Ellertsen, Linda K Nygaard, Unni C Melkild, Ingrid Løvik, Martinus BMC Immunol Research article BACKGROUND: Allergy has been an increasing problem in several parts of the world. Prenatal exposure to allergen and microbial components may affect the development of allergies in childhood, as indicated by epidemiological and experimental studies. We investigated the capacity for allergic sensitisation in offspring after induction of a Th1- or a Th2-polarised immune response to the same allergen in mothers during pregnancy. RESULTS: During pregnancy, mice were immunised with ovalbumin (OVA) given with either one of the Th2-adjuvants pertussis toxin (PT) or Al(OH)(3 )(aluminium hydroxide), or with the Th1 adjuvant CpG. Offspring were immunised with OVA in Al(OH)(3 )as young adults. Serum and supernatants from ex vivo stimulated or non-stimulated spleen cells from mothers and offspring were analysed for OVA-specific antibodies and cytokines, respectively. Mothers immunised with OVA together with either Al(OH)(3 )or PT had increased levels of OVA-specific IgE and IgG1 compared to naive mothers, whereas mothers immunised with OVA together with CpG had increased levels of OVA-specific IgG2a compared to naive mothers. In general the highest levels of IL-5, IL-10, and IFNγ were observed in spleen cells from mothers immunised with PT and OVA. Upon immunisation, offspring from mothers immunised with OVA and either PT or Al(OH)(3 )showed reduced levels of OVA-specific IgE and IgG1 and increased levels of OVA-specific IgG2a antibodies compared to offspring from naive mothers. Maternal immunisation with CpG and OVA did not affect antibody responses in offspring. CONCLUSION: Allergic sensitisation in the offspring was affected by the type of adjuvant used for immunisation of the mothers with the same allergen. Th2 polarisation of the immune response in the mothers was found to give reduced IgE levels upon sensitisation of the offspring, whereas no reduction was achieved with Th1 polarisation in the mothers. BioMed Central 2010-03-01 /pmc/articles/PMC2846879/ /pubmed/20193059 http://dx.doi.org/10.1186/1471-2172-11-8 Text en Copyright ©2010 Ellertsen et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research article
Ellertsen, Linda K
Nygaard, Unni C
Melkild, Ingrid
Løvik, Martinus
Maternal allergen immunisation to prevent sensitisation in offspring: Th2-polarising adjuvants are more efficient than a Th1-polarising adjuvant in mice
title Maternal allergen immunisation to prevent sensitisation in offspring: Th2-polarising adjuvants are more efficient than a Th1-polarising adjuvant in mice
title_full Maternal allergen immunisation to prevent sensitisation in offspring: Th2-polarising adjuvants are more efficient than a Th1-polarising adjuvant in mice
title_fullStr Maternal allergen immunisation to prevent sensitisation in offspring: Th2-polarising adjuvants are more efficient than a Th1-polarising adjuvant in mice
title_full_unstemmed Maternal allergen immunisation to prevent sensitisation in offspring: Th2-polarising adjuvants are more efficient than a Th1-polarising adjuvant in mice
title_short Maternal allergen immunisation to prevent sensitisation in offspring: Th2-polarising adjuvants are more efficient than a Th1-polarising adjuvant in mice
title_sort maternal allergen immunisation to prevent sensitisation in offspring: th2-polarising adjuvants are more efficient than a th1-polarising adjuvant in mice
topic Research article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2846879/
https://www.ncbi.nlm.nih.gov/pubmed/20193059
http://dx.doi.org/10.1186/1471-2172-11-8
work_keys_str_mv AT ellertsenlindak maternalallergenimmunisationtopreventsensitisationinoffspringth2polarisingadjuvantsaremoreefficientthanath1polarisingadjuvantinmice
AT nygaardunnic maternalallergenimmunisationtopreventsensitisationinoffspringth2polarisingadjuvantsaremoreefficientthanath1polarisingadjuvantinmice
AT melkildingrid maternalallergenimmunisationtopreventsensitisationinoffspringth2polarisingadjuvantsaremoreefficientthanath1polarisingadjuvantinmice
AT løvikmartinus maternalallergenimmunisationtopreventsensitisationinoffspringth2polarisingadjuvantsaremoreefficientthanath1polarisingadjuvantinmice